References
- Cork M, Britton J, Butler L, et al. Comparison of parent knowledge, therapy utilization and severity of atopic eczema before and after explanation and demonstration of topical therapies by a specialist dermatology nurse. Br J Dermatol. 2003;149(3):582–589.
- Greenlaw SM, Yentzer BA, O’Neill JL, et al. Assessing adherence to dermatology treatments: a review of self-report and electronic measures. Skin Res Technol. 2010;16(2):253–258.
- Neri L, Peris K, Longo C, et al. Physician-patient communication and patient-reported outcomes in the actinic keratosis treatment adherence initiative (AK-TRAIN): a multicenter, prospective, real-life study of treatment satisfaction, quality of life and adherence to topical field-directed therapy for the treatment of actinic keratosis in Italy. J Eur Acad Dermatol Venereol. 2019;33(1):93–107.
- Carroll CL, Feldman SR, Camacho FT, et al. Better medication adherence results in greater improvement in severity of psoriasis. Br J Dermatol. 2004;151(4):895–897.
- Feldman SR, Vrijens B, Gieler U, et al. Treatment adherence intervention studies in dermatology and guidance on how to support adherence. Am J Clin Dermatol. 2017;18(2):253–271.
- Ahn CS, Culp L, Huang WW, et al. Adherence in dermatology. J Dermatolog Treat. 2017;28(2):94–103.
- Gast A, Mathes T. Medication adherence influencing factors-an (updated) overview of systematic reviews. Syst Rev. 2019;8(1):112.
- Hodari KT, Nanton JR, Carroll CL, et al. Adherence in dermatology: a review of the last 20 years. J Dermatolog Treat. 2006;17(3):136–142.
- Piaserico S, Manfredini S, Borghi A, et al. How to improve adherence to treatment in patients with mild-to-moderate psoriasis. G Ital Dermatol Venereol. 2018;153(5):692–697.
- Schumock GT, Vermeulen LC. The rising cost of prescription drugs: causes and solutions. Pharmacotherapy. 2017;37(1):9–11.
- Rosenberg ME, Rosenberg SP. Changes in retail prices of prescription dermatologic drugs from 2009 to 2015. JAMA Dermatol. 2016;152(2):158–163.
- Gourzoulidis G, Kourlaba G, Stafylas P, et al. Association between copayment, medication adherence and outcomes in the management of patients with diabetes and heart failure. Health Policy. 2017;121(4):363–377.
- Neighmond P When insurance won’t cover drugs, Americans make ‘tough choices’ about their health 2020 [ updated 2020 Jan 27].
- Ryskina KL, Goldberg E, Lott B, et al. The role of the physician in patient perceptions of barriers to primary adherence with acne medications. JAMA Dermatol. 2018;154(4):456–459.
- Vangeli E, Bakhshi S, Baker A, et al. A systematic review of factors associated with non-adherence to treatment for immune-mediated inflammatory diseases. Adv Ther. 2015;32(11):983–1028.
- Choudhry N, Avorn J, Glynn R, et al. Full coverage for preventive medications after myocardial infarction. N Engl J Med. 2011;365(22):2088–2097.
- Steen AJ, Mann JA, Carlberg VM, et al. Understanding the cost of dermatologic care: a survey study of dermatology providers, residents, and patients. J Am Acad Dermatol. 2017;76(4):609–617.
- Asarch A, Chiu A, Kimball A, et al. Survey research in dermatology: guidelines for success. Dermatol Clin. 2009;27(2):121–131.
- Dillman D, Smyth J, Christian L. Internet, mail, and mixed-mode surveys: the tailored design method. 3rd ed. United States: Wiley and Sons; 2009. p. 528.
- World Medical Association. World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2013;310(20):2191–2194.
- Khera R, Valero-Elizondo J, Das SR, et al. Cost-related medication nonadherence in adults with atherosclerotic cardiovascular disease in the United States, 2013 to 2017. Circulation. 2019;140(25):2067–2075.
- Heidari P, Cross W, Weller C, et al. Medication adherence and cost-related medication non-adherence in patients with rheumatoid arthritis: a cross-sectional study. Int J Rheum Dis. 2019;22(4):555–566.
- Allan G, Lexchin J, Wiebe N. Physician awareness of drug cost: a systematic review. PLoS Med. 2007;4(9):1486–1496.
- Reichert S, Simon T, Halm E. Physicians’ attitudes about prescribing and knowledge of the costs of common medications. Arch Intern Med. 2000;160(18):2799–2803.
- DeMarco SS, Paul R, Kilpatrick RJ. Information system technologies’ role in augmenting dermatologists’ knowledge of prescription medication costs. Int J Med Inform. 2015;84(12):1076–1084.
- El-Dahiyat F, Kayyali R, Bidgood P. Physicians’ perception of generic and electronic prescribing: a descriptive study from Jordan. J Pharm Policy Pract. 2014;7(7):1–8.
- Al-Mohamadi A, Al-Harbi AM, Manshi AM, et al. Medications prescribing pattern toward insured patients. Saudi Pharm J. 2014;22(1):27–31.
- Kratzer J, Cheng L, Allin S, et al. The impact of private insurance coverage on prescription drug use in Ontario, Canada. Healthc Policy. 2015;10(4):62–74.
- Alonso TR, Gagol A, Scherer M, et al. A multivariate investigation into the relationship between pharmaceutical characteristics and patient preferences of bioequivalent ibuprofen tablets. Patient Prefer Adherence. 2018;12:1927–1935.
- Seidler A, Kini S, DeLong L, et al. Preference-based measures in dermatology: an overview of utilities and willingness to pay. Dermatol Clin. 2012;30(2):223–229.
- El-Dahiyat F, Kayyali R. Evaluating patients’ perceptions regarding generic medicines in Jordan. J Pharm Policy Pract. 2013;6(3). DOI:10.1186/2052-3211-6-3
- Osborn CY, Kripalani S, Goggins KM, et al. Financial strain is associated with medication nonadherence and worse self-rated health among cardiovascular patients. J Health Care Poor Underserved. 2017;28(1):499–513.
- Law M, Cheng L, Dhalla I, et al. The effect of cost on adherence to prescription medications in Canada. CMAJ. 2012;184(3):297–302.